We are live on !
Find out more
Commonwealth Equity Services Portfolio holdings
AUM
$79.5B
Turnover
11.02%
1-Year Est. Return
27.1%
This Fund
S&P 500
This Quarter Est. Return
+15.68%
1 Year Est. Return
+27.1%
3 Year Est. Return
+78.53%
5 Year Est. Return
+87.9%
10 Year Est. Return
+281.22%
AUM
$79.5B
AUM Growth
+$7.93B
(+11%)
Cap. Flow
-$643M
Cap. Flow % of AUM
Cap. Flow %
-0.81%
Top 10 Holdings %
Top 10 Hldgs %
16.98%
Holding
4,611
New
312
Increased
1,846
Reduced
2,170
Closed
196
Avg Time Held
5.9
years
Top 10 Avg Time Held
8.7
years
Top 20 Avg Time Held
7.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$70M |
| 2 |
Putnam Focused Large Cap Value ETF
PVAL
|
+$65.3M |
| 3 |
Fidelity Fundamental Large Cap Growth ETF
FFLG
|
+$50M |
| 4 |
Eli Lilly
LLY
|
+$42.5M |
| 5 |
SpaceX
SPCX
|
+$40.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$122M |
| 2 |
NVIDIA
NVDA
|
+$99.2M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.3M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$79.7M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$69.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 66.62% |
| 2 | Technology | 12.02% |
| 3 | Financials | 4.01% |
| 4 | Industrials | 3.47% |
| 5 | Consumer Discretionary | 3.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2576
Brighthouse Financial
BHF
$2.61B
| $1.2M | ﹤0.01% |
18,918
-397
| -2% | -$24.7K |
2020 Q4
22 quarters
|
|
2577
Northwest Natural Holdings
NWN
$2.1B
| $1.2M | ﹤0.01% |
24,358
-618
| -2% | -$31.7K |
2013 Q2
52 quarters
|
|
2578
First Trust NASDAQ 100 ex-Technology Sector Index Fund
QQXT
$134M
| $1.19M | ﹤0.01% |
12,238
-2,698
| -18% | -$265K |
2020 Q3
23 quarters
|
|
2579
First Horizon
FHN
$11.1B
| $1.19M | ﹤0.01% |
46,592
-709
| -1% | -$17.3K |
2020 Q1
25 quarters
|
|
2580
Pacer Swan SOS Moderate October ETF
PSMO
$106M
| $1.19M | ﹤0.01% |
36,694
| – | – |
2022 Q4
14 quarters
|
|
2581
Candel Therapeutics
CADL
$614M
| $1.19M | ﹤0.01% |
115,875
+20,480
| +21% | +$155K |
2024 Q4
6 quarters
|
|
2582
SS&C Technologies
SSNC
$19.5B
| $1.19M | ﹤0.01% |
19,230
+2,857
| +17% | +$194K |
2018 Q1
33 quarters
|
|
2583
Roundhill GLP-1 & Weight Loss ETF
OZEM
$55.4M
| $1.19M | ﹤0.01% |
36,666
+756
| +2% | +$23.6K |
2024 Q3
7 quarters
|
|
2584
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.19M | ﹤0.01% |
37,949
-11,432
| -23% | -$337K |
2015 Q1
45 quarters
|
|
2585
IPG Photonics
IPGP
$3.02B
| $1.19M | ﹤0.01% |
10,129
+348
| +4% | +$40K |
2015 Q4
42 quarters
|
|
2586
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$258M
| $1.19M | ﹤0.01% |
17,178
-999
| -5% | -$67.1K |
2013 Q2
52 quarters
|
|
2587
Intellia Therapeutics
NTLA
$1.57B
| $1.19M | ﹤0.01% |
70,210
-23,976
| -25% | -$336K |
2018 Q1
33 quarters
|
|
2588
CVB Financial
CVBF
$4.02B
| $1.18M | ﹤0.01% |
52,530
+4,344
| +9% | +$89.2K |
2013 Q2
52 quarters
|
|
2589
Invesco Biotechnology & Genome ETF
PBE
$428M
| $1.18M | ﹤0.01% |
13,211
-1,078
| -8% | -$88.8K |
2013 Q2
52 quarters
|
|
2590
VanEck Pharmaceutical ETF
PPH
$1.12B
| $1.18M | ﹤0.01% |
10,821
-1,021
| -9% | -$106K |
2020 Q2
24 quarters
|
|
2591
PGIM US Large-Cap Buffer 20 ETF - December
PBDE
$38.4M
| $1.18M | ﹤0.01% |
38,186
-9,437
| -20% | -$287K |
2024 Q4
6 quarters
|
|
2592
Liberty All-Star Equity Fund
USA
$1.83B
| $1.18M | ﹤0.01% |
203,254
+14,950
| +8% | +$86.3K |
2013 Q2
52 quarters
|
|
2593
Palomar
PLMR
$3.73B
| $1.18M | ﹤0.01% |
9,334
-94
| -1% | -$11.1K |
2025 Q1
5 quarters
|
|
2594
Invesco DB Agriculture Fund
DBA
$1.2B
| $1.18M | ﹤0.01% |
44,201
+10,031
| +29% | +$274K |
2021 Q1
21 quarters
|
|
2595
Crawford & Co Class A
CRD.A
$591M
| $1.18M | ﹤0.01% |
104,536
+37
| +0% | +$393 |
2022 Q2
16 quarters
|
|
2596
Innovator Equity Dual Directional 10 Buffer ETF - November
DDTN
$36.2M
| $1.18M | ﹤0.01% |
57,765
-399
| -0.7% | -$7.97K |
2025 Q4
2 quarters
|
|
2597
First American
FAF
$6.61B
| $1.18M | ﹤0.01% |
17,164
+1,662
| +11% | +$111K |
2017 Q2
36 quarters
|
|
2598
Essential 40 Stock ETF
ESN
$357M
| $1.17M | ﹤0.01% |
58,995
+4,953
| +9% | +$94.3K |
2025 Q4
2 quarters
|
|
2599
Calumet Specialty Products
CLMT
$4.33B
| $1.17M | ﹤0.01% |
32,551
+106
| +0.3% | +$3.56K |
2016 Q1
41 quarters
|
|
2600
MSC Industrial Direct
MSM
$6.36B
| $1.17M | ﹤0.01% |
9,843
-1,352
| -12% | -$144K |
2020 Q3
23 quarters
|
|
Similar funds
Commonwealth Equity Services's Q2 2026 Portfolio in Review
As of Q2 2026, Commonwealth Equity Services held 4,611 positions worth $79.5B, up 11% from $71.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Commonwealth Equity Services's Q2 2026 filing shows 312 new, 1,846 increased, 2,170 reduced and 196 closed positions. Its largest new stake was SpaceX: 238,120 shares worth $40.7M. The largest sale was Apple, an estimated $122M.
By sector, the portfolio is most concentrated in Miscellaneous at 67% of assets, up from 66% a quarter earlier, followed by Technology and Financials.
- Commonwealth Equity Services's largest Q2 2026 buy was SpaceX: 238,120 shares worth $40.7M.
- Commonwealth Equity Services added most to Invesco NASDAQ 100 ETF in Q2 2026, an estimated $70M increase.
- Commonwealth Equity Services's biggest Q2 2026 reduction was Apple, cutting an estimated $122M.
- Commonwealth Equity Services fully exited Convergence Long/Short Equity ETF in Q2 2026, selling an estimated $7.88M.
- Commonwealth Equity Services's ten largest holdings make up 17% of its $79.5B portfolio in Q2 2026.
- Commonwealth Equity Services opened 312 new positions and closed 196 in Q2 2026.
- Commonwealth Equity Services's portfolio value rose 11% quarter-over-quarter to $79.5B.
Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.